Global Platelet-Rich Plasma Market Analysis, Drivers, Restraints, Opportunities, Threats, Trends, Applications, and Growth Forecast to 2027

“Global Platelet-Rich Plasma Market Analysis Trends, Applications, Analysis, Growth, and Forecast to 2027” is a recent report generated by MarketResearch.biz, which offers in-depth insights, revenue details, and other vital information regarding the global platelet-rich plasma market, and the various trends, drivers, restraints, opportunities, and threats in the target market till 2027. The report offers insightful and detailed information regarding the various key players operating in the market, their financials, supply chain trends, technological innovations, key developments, apart from future strategies, acquisitions & mergers, and market footprint. The global platelet-rich plasma market report has been segmented on the basis of type, origin, application, and region.

Introduction:

Platelet-rich plasma (PRP) is also known as autologous conditioned plasma. Platelets are cytoplasmic fragments of megakaryocytes, formed in the marrow and approximately 2 mm in diameter. PRP is plasma with many more platelets than typically found in blood. The concentration of platelets is 5 to 10 times more than usual. Platelet activation plays an important role in the process of wound and soft tissue healing such as injured tendons, ligaments, muscles, and joints, etc. PRP is prepared by a process known as differential centrifugation. In differential centrifugation, acceleration force is adjusted to sediment certain cellular constituents based on different specific gravity. PRP provides an immediate surgical hemostatic agent that is biocompatible, safe, and effective.

Market Dynamics:

Key factors expected to drive growth of the global platelet-rich plasma market is increasing number of orthopedic surgeries and sports injuries. In addition, increasing demand for minimal invasive surgical procedure, rising healthcare expenditure, increasing incidences of chronic diseases, growing elderly population, increasing application of PRP in various applicants such as cosmetic, general’s surgery, etc. are among some other factors expected to drive growth of the global platelet-rich plasma market. Furthermore, the increasing number of cosmetic surgeries, growing awareness regarding healthcare, availability advance medical facilities, are other factors expected to drive revenue growth of the target market over the forecast years. However, string regulatory rule and high cost may hamper the growth of the global target market to a certain extend.

Trends:

The major player in the global target market along with government support are focusing on R&D activities, in order to developed advance product to cater the growing demand for platelet-rich plasma for various applications such as orthopedic surgery, neurosurgery, cosmetic surgery, general surgery, etc. For instance, in 2018, Bellus Medical collaborated with RegenLab, in order to developed advanced products for PRP and cell therapy.

Regional Analysis:

The market in North America is expected to dominate the global platelet-rich plasma market, owing to widely used in cosmetic surgeries to improve facial esthetics, enhance the rate of injury healing in countries in the region. In contrast, the market in Asia Pacific is expected to be an emerging market for the global target market, and is expected to register highest CAGR in during the forecasted period. This is primarily attributed to high prevalence of orthopedic disease, developing healthcare infrastructure in country in the region. Moreover, the markets in Europe, Latin America and Middle East & Africa are expected to register moderate growth rate over the forecast period.

GLOBAL PLATELET-RICH PLASMA MARKET SEGMENTATION:

Segmentation by type:

• Pure PRP
• Leukocyte-rich PRP
• Pure Platelet-rich Fibrin

Segmentation by origin:

• Autologous
• Allogeneic
• Homologous

Segmentation by application:

• Orthopedic Surgery
• Neurosurgery
• Cosmetic Surgery
• General Surgery
• Others (includes Orthopedics, Cardiothoracic Surgery, etc.)

Segmentation by region:

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

• Harvest Technologies Corp. (Terumo Corporation)
• Arthrex, Inc.
• Zimmer Biomet Holdings, Inc.
• EmCyte Corporation
• Regen Lab SA
• Exactech, Inc.
• Cesca Therapeutics, Inc.
• Nuo Therapeutics, Inc.
• DePuy Synthes (Johnson & Johnson)
• AdiStem Ltd.